Financial insights of BIAF

MyFinsight

For the quarter ending 2026-03-31, BIAF made $1,351,527 in revenue. -$3,630,610 in net income. Net profit margin of -268.63%.

Income Statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Net revenue	1,351,527	2,088,635.5*	1,446,066	1,269,483
Direct costs and expenses	928,636	1,288,579.5*	942,211	1,016,602
Research and development	349,707	420,417.5*	330,589	311,372
Clinical development	334,040	296,859*	143,311	129,279
Selling, general and administrative	3,241,602	3,277,726*	2,209,441	2,214,561
Depreciation and amortization	114,518	164,952.5*	113,360	113,229
Total operating expenses	4,968,503	5,448,534.5*	3,738,912	3,785,043
Loss from operations	-3,616,976	-3,359,899*	-2,292,846	-2,515,560
Interest income	10,026	18,715.5*	1,088	2,025
Interest expense	14,722	20,645*	5,358	10,460
Other income	-	-17,359*	513	38,053
Other expense	8,938	-227,894*	3,839	483,043
Change in fair value of warrants issued	-	-1,905,139*	2,747,460	1,062,818
Total other expense	-13,634	-	-2,755,056	-1,516,243
Net loss before provision for income taxes	-3,630,610	-1,246,154.5*	-5,047,902	-4,031,803
Income tax expense	-	-4,207*	3,182	28,984
Net loss	-3,630,610	-1,241,947.5	-5,051,084	-4,060,787

Basic EPS	-0.81	-0.722	-4.74	-0.17
Diluted EPS	-0.81	-0.722	-4.74	-0.17
Basic Average Shares	4,494,752	1,721,082*	1,066,350	24,021,546
Diluted Average Shares	4,494,752	1,721,082*	1,066,350	24,021,546